Discovery Value Fund Bei Gene, Ltd. Transaction History

Discovery Value Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$115.78 - $208.34 $3.11 Million - $5.6 Million	-26,863 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$113.99 - $146.86 $2.05 Million - $2.64 Million	-18,000 Reduced 40.12%	26,863 $3.33 Million
Q1 2019 May 07, 2019	BUY	$122.82 - $151.83 $478,998 - $592,137	3,900 Added 9.52%	44,863 $5.92 Million
Q4 2018 Jan 31, 2019	BUY	$107.01 - $175.15 $4.38 Million - $7.17 Million	40,963 New	40,963 $5.75 Million

212

45.1M

106K

93.1K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $24.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Discovery Value Fund, based on Form 13F filings with the SEC.

Stay updated on Discovery Value Fund with notifications on news.